Britain on Thursday launched a trial to assess the immune responses generated if doses of the Covid-19 vaccines from Pfizer and AstraZeneca are combined in a two-shot schedule.
WATCH MORE: https://thestartv.com/c/news
SUBSCRIBE: https://cutt.ly/TheStar
LIKE: https://fb.com/TheStarOnline